Netherlands
5 Vaccines Approved for Use in Netherlands
Protein Subunit
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu
7 in Clinical Trials in Netherlands
Protein Subunit
University Medical Center Groningen
AKS-452
4 trials in 2 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
RNA
Moderna
Spikevax
Approved in 86 countries
63 trials in 22 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Protein Subunit
University Medical Center Groningen
AKS-452X
VLP
Radboud University
ABNCoV2
4 trials in 2 countries
Inactivated
Valneva
VLA2001
Approved in 3 countries
6 trials in 3 countries
1 Vaccines with Trials in Netherlands are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries